In liver cancers, FZC18 immunostaining negatively correlates with Wnt/β−catenin signaling and with the protein expression of the β−catenin-regulated gene GS, consistently with the suppression of GS synthesis by DKK1 in mice carrying an APC disruption [13]. The gene discussed is APC; the disease is liver cancer.